Global Anorexia Nervosa Clinical Trials Review, H2, 2018 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Anorexia
Nervosa Global Clinical Trials Review, H2, 2018” clinical
trials has been added to ResearchAndMarkets.com’s
offering.

Anorexia Nervosa Global Clinical Trials Review, H2, 2018 provides an
overview of Anorexia Nervosa clinical trials scenario. This report
provides top line data relating to the clinical trials on Anorexia
Nervosa. Report includes an overview of trial numbers and their average
enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor type.
Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials). These reports are generated using a
proprietary database – Pharma eTrack Clinical trials database. Clinical
trials are collated from 80+ different clinical trial registries,
conferences, journals, news etc across the globe. Clinical trials
database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by
  Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and
  End point status
• The report reviews top companies involved and enlists all trials
  (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated,
  Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Reasons to Buy

• Assists in formulating key business strategies with regards to
  investment
• Helps in identifying prominent locations for conducting clinical
  trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which
  helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by
  country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing
  a comparative scenario of completed and uncompleted (terminated,
  suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global,
  regional and country level

Key Topics Covered:

1. List of Tables & Figures
2. Report Guidance
3. Clinical Trials Report Coverage
4. Clinical Trials by Region
5. Clinical Trials and Average Enrollment by Country
6. Top Five Countries Contributing to Clinical Trials in Asia-Pacific
7. Top Five Countries Contributing to Clinical Trials in Europe
8. Top Countries Contributing to Clinical Trials in North America
9. Top Countries Contributing to Clinical Trials in Middle East and Africa
10. Clinical Trials by G7 Countries: Proportion of Anorexia Nervosa to
    Central Nervous System Clinical Trials
11. Clinical Trials by Phase in G7 Countries
12. Clinical Trials in G7 Countries by Trial Status
13. Clinical Trials by E7 Countries: Proportion of Anorexia Nervosa to
    Central Nervous System Clinical Trials
14. Clinical Trials by Phase in E7 Countries
15. Clinical Trials in E7 Countries by Trial Status
16. Clinical Trials by Phase
17. In Progress Trials by Phase
18. Clinical Trials by Trial Status
19. Clinical Trials by End Point Status
20. Subjects Recruited Over a Period of Time
21. Clinical Trials by Sponsor Type
22. Prominent Sponsors
23. Top Companies Participating in Anorexia Nervosa Therapeutics Clinical
    Trials
24. Prominent Drugs
25. Clinical Trial Profile Snapshots
26. Appendix

Companies Mentioned

• Insys Therapeutics Inc
• Tsumura & co
• Endo International Plc
• Eli Lilly and Co
• Daewoong Co Ltd
• Worldwide Clinical Trials Holdings Inc
• SFBC Anapharm
• Pharma Medica Research Inc
• Bristol-Myers Squibb Co
• Allergan Plc

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/m561oa

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials, Mental
Health